Check out Woodland Bioscience's new ad coming out September 16th, 2020!

Upcoming Events

Discover what Woodland Biosciences presented at previous events we attended.

At Woodland Biosciences, we strive to be the best in the industry, making sure our users get the best products and services in the market. Don’t miss out on any of our upcoming events; take a look at the schedule below.

AACR 2020 in San Diego, CA ~ CANCELLED ~

(Rescheduled Date TBD)

AACR 2020 has been postponed. Woodland will reevaluate attendance when the new scheduled date has been released. For more information, please visit AACR's website.


Woodland would have presented new data on human primary HCC orthotopically implanted into human hepatocytes in the Yecuris FRG® mice.

AASLD The Liver Meeting 2020 ~ CANCELLED ~

November 13-17, 2020

Woodland will be attending AASLD next November 13-17, 2020 in Boston, MA.

Past Events

Discover what Woodland Biosciences presented at previous events we attended.

The American Liver Association's Arias Symposium at the Broad Institute

November 13, 2019

Woodland is a contributing sponsor of the Arias Symposium, come visit us today from 8am - 1:30pm at the Broad Institute at 415 Main Street Cambridge, MA.

AASLD - The Liver Meeting Boston, MA

November 8-12, 2019

Woodland had a booth at the AASLD Liver Meeting this November. 

NASH Summit 2019 Boston, MA

April 22-25, 2019

Woodland attended the 2019 NASH Summit with a booth describing our expertise in liver fibrosis and metabolic pathologies. 

Dr. Briggs, President and CSO of Woodland Biosciences presented a short oral presentation of Woodland's research and development into more clinically relevant modeling of liver fibrosis and the sequelae of fibrosis and cirrhosis, namely HCC.  


If you missed the presentation "NASH - Fibrosis and Beyond", you can download a copy below or schedule a call to discuss the presentation more with Dr. Briggs.


Mike Talking 1.jpg

AACR 2019 Atlanta, GA

March 29 - April 3, 2019

Dr. Briggs attended the AACR in Atlanta, GA this past March. 

AACR Chicago

April 17, 2018

Poster #4088 "Metabolic disease drivers of liver cancer, a new disease paradigm", presented by Dr. Michael R. Briggs, President & CSO, Woodland Pharmaceuticals, LLC, USA

Much of the global burden of HCC until recently has been caused by alcohol abuse and Hepatitis viruses (HepB & HepC). With a vaccine for HepB being widely used in Asian countries and multi-drug cocktails to effectively cure much HepC, these drivers of HCC will be reduced in the future, ironically HCC continues to be one of the few cancers growing in incidence. It is postulated that the global obesity epidemic is fueling a new etiology of HCC, through fatty liver disease, non-alcoholic steatohepatitis (NASH) and cirrhosis. Liver and pancreatic cancers are projected to continue to increase in incidence for the foreseeable future. And distressingly, for the first time, children are being diagnosed with NASH. We have undertaken the development of a mouse model of NASH leading to HCC and performed a longitudinal analysis of liver samples through the phenotypes of obesity and hyperglycemia, inflammation and fibrosis leading to hyperproliferative disease and HCC to begin to map out the pathways and biomarkers of this metabolically-driven liver cancer for comparison to human clinical data and biomarkers of disease progression to HCC. 

Transgenic Animals

Society of Toxicology

March 14, 2018

Annual Meeting 2018 located in San Antonio, Texas
Industry Sponsored Session
Co-presenting with GVK BioSciences

College Campus

Department of Molecular Microbiology and Immunology Seminar Series

March 8, 2018

Speaker series at St. Louis University in Missouri.

Washington Monument

The Liver Meeting® 2017

October 20, 2017

Woodland co-authored two NASH posters at 2017 AASLD in Washington, D.C.  Posters available on request.

Castle Scotland

Predictive, Preventive & Personalized Medicine and Molecular Diagnostics

September 14, 2017

Woodland President Michael Briggs was an invited speaker at the 6th European Conference on Predictive, Preventive and Personalized Medicine & Molecular Diagnostics, held in Edinburgh, Scotland on September 14.